[Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab. 2006 update].
作者信息
López-San Román A, Obrador A, Fortún J, Muñoz P, Gassull M A
机构信息
Servicio de Gastroenterología, Hospital Ramón y Cajal, Madrid, Spain.
出版信息
Gastroenterol Hepatol. 2006 Feb;29(2):81-4. doi: 10.1157/13083915.
DOI:10.1157/13083915
PMID:16448610
Abstract
摘要
相似文献
1
[Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab. 2006 update].
Gastroenterol Hepatol. 2006 Feb;29(2):81-4. doi: 10.1157/13083915.
2
[Consensus guideline on tuberculosis and treatment of inflammatory bowel disease with infliximab. Spanish Working Group on Crohn Disease and Ulcerative Colitis].
Gastroenterol Hepatol. 2003 Jan;26(1):29-33. doi: 10.1016/s0210-5705(03)70338-0.
3
Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment.
J Crohns Colitis. 2016 Oct;10(10):1186-93. doi: 10.1093/ecco-jcc/jjw022. Epub 2016 Jan 22.
4
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study.
Gut. 2009 Apr;58(4):501-8. doi: 10.1136/gut.2008.163642. Epub 2008 Oct 2.
5
Immunosuppressive monoclonal antibodies: current and next generation.
Clin Microbiol Infect. 2011 Dec;17(12):1759-68. doi: 10.1111/j.1469-0691.2011.03677.x. Epub 2011 Oct 13.
6
Immortal time bias and infliximab-related mortality and malignancy incidence.
Gut. 2010 Mar;59(3):416; author reply 416. doi: 10.1136/gut.2009.186445.
7
Association of multiple myeloma and inflammatory bowel diseases.
Dig Dis Sci. 2008 Mar;53(3):863-4. doi: 10.1007/s10620-007-9932-z. Epub 2007 Aug 24.
8
Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy.
Rev Esp Enferm Dig. 2010 Oct;102(10):614-6. doi: 10.4321/s1130-01082010001000014.
9
Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.
J Crohns Colitis. 2016 Oct;10(10):1179-85. doi: 10.1093/ecco-jcc/jjw129. Epub 2016 Jul 11.
10
Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment.
J Gastroenterol Hepatol. 2018 Jan;33(1):20-29. doi: 10.1111/jgh.14019.
引用本文的文献
1
Tuberculin skin testing in inflammatory bowel disease patients from an endemic area of Brazil.
Braz J Infect Dis. 2014 Jan-Feb;18(1):60-4. doi: 10.1016/j.bjid.2013.05.008. Epub 2013 Sep 20.
2
Infectious pulmonary complications in patients treated with anti-TNF-alpha monoclonal antibodies and soluble TNF receptor.
Curr Infect Dis Rep. 2009 May;11(3):229-36. doi: 10.1007/s11908-009-0034-2.
3
Timing of surgery in Crohn's disease: a key issue in the management.
World J Gastroenterol. 2008 Sep 28;14(36):5532-9. doi: 10.3748/wjg.14.5532.
Zotero 插件